Micro- and nanocarrier-mediated lung targeting (Q37766234)

22 August 2017

1 reference

title

Micro- and nanocarrier-mediated lung targeting (English)

1 reference

22 August 2017

1 reference

Balak D Kurmi

1

1 reference

22 August 2017

Jitendra Kayat

2

1 reference

22 August 2017

Virendra Gajbhiye

3

1 reference

22 August 2017

Rakesh K Tekade

4

1 reference

22 August 2017

Narendra K Jain

5

1 reference

22 August 2017

language of work or name

English

0 references

publication date

1 July 2010

1 reference

Expert Opinion on Drug Delivery

22 August 2017

1 reference

22 August 2017

7

1 reference

22 August 2017

781-794

1 reference

22 August 2017

7

1 reference

Targeted delivery of nanoparticles for the treatment of lung diseases.

22 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.492212

Pulmonary drug delivery systems: recent developments and prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.492212

Techniques for drug delivery to the airways, and the assessment of lung function in animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.492212

Prediction of drug residence times in regions of the human respiratory tract following aerosol inhalation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.492212

Day-night patterns in bronchial patency and dyspnea: basis for once-daily and unequally divided twice-daily theophylline dosing schedules

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.492212

Sustained release of insulin from sodium hyaluronate based dry powder formulations after pulmonary delivery to beagle dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.492212

Novel sustained release microspheres for pulmonary drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.492212

Sustained release drug delivery to the lungs: an option for the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.492212

Chitosan microspheres for intrapulmonary administration of moxifloxacin: interaction with biomembrane models and in vitro permeation studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.492212

Studies on the poly(lactic-co-glycolic) acid microspheres of cisplatin for lung-targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.492212

Lung-targeting microspheres of carboplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.492212

Development of highly porous large PLGA microparticles for pulmonary drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.492212

In vitro development of resistance to enrofloxacin, erythromycin, tylosin, tiamulin and oxytetracycline in Mycoplasma gallisepticum, Mycoplasma iowae and Mycoplasma synoviae.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.492212

Pharmacokinetics and lung-targeting characterization of a newly formulated enrofloxacin preparation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.492212

Respirable PLGA microspheres containing rifampicin for the treatment of tuberculosis: screening in an infectious disease model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.492212

Efficient intracellular delivery of rifampicin to alveolar macrophages using rifampicin-loaded PLGA microspheres: effects of molecular weight and composition of PLGA on release of rifampicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.492212

Inhalable microparticles containing drug combinations to target alveolar macrophages for treatment of pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.492212

Novel conjugate of moxifloxacin and carboxymethylated glucan with enhanced activity against Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.492212

Inhalable microparticles containing large payload of anti-tuberculosis drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.492212

Mucosal delivery of microparticle encapsulated ESAT-6 induces robust cell-mediated responses in the lung milieu.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.492212

Effects of lung surfactants on rifampicin release rate from monodisperse rifampicin-loaded PLGA microspheres.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.492212

Clarithromycin targeting to lung: characterization, size distribution and in vivo evaluation of the human serum albumin microspheres.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.492212

Emergence of ofloxacin resistance in Mycobacterium tuberculosis clinical isolates from China as determined by gyrA mutation analysis using denaturing high-pressure liquid chromatography and DNA sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.492212

Hyaluronic acid: a unique topical vehicle for the localized delivery of drugs to the skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.492212

CD44 is a phagocytic receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.492212

Can exogenously administered hyaluronan improve respiratory function in patients with pulmonary emphysema?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.492212

Effect of an intrathoracic injection of sodium hyaluronic acid on the prevention of pleural thickening in excess fluid of tuberculous thoracic cavity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.492212

Delivery of ofloxacin to the lung and alveolar macrophages via hyaluronan microspheres for the treatment of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.492212

Preparation, characterization and in vivo distribution of terbutaline sulfate loaded albumin microspheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.492212

Nanoparticles for drug delivery in cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.492212

Doxorubicin-loaded PLGA nanoparticles by nanoprecipitation: preparation, characterization and in vitro evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.492212

Functionalized micellar systems for cancer targeted drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.492212

PEGylation, successful approach to drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.492212

Nanoparticle imaging of integrins on tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.492212

Selective attachment and release of a chemotherapeutic agent from the interior of a protein cage architecture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.492212

Immunonanoshells for targeted photothermal ablation of tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.492212

A PEGylated dendritic nanoparticulate carrier of fluorouracil

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.492212

PEGylated nanoparticles for biological and pharmaceutical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.492212

Systemic targeting of metastatic human breast tumor xenografts by Coxsackievirus A21.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.492212

ICAM-1 targeting of doxorubicin-loaded PLGA nanoparticles to lung epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.492212

Development of gelatin nanoparticles with biotinylated EGF conjugation for lung cancer targeting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.492212

Incorporation of biodegradable nanoparticles into human airway epithelium cells-in vitro study of the suitability as a vehicle for drug or gene delivery in pulmonary diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.492212

Nanocomposites of lung surfactant and biodegradable cationic nanoparticles improve transfection efficiency to lung cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.492212

Studies on bioadhesive PLGA nanoparticles: A promising gene delivery system for efficient gene therapy to lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.492212

Pulmonary delivery of insulin with nebulized DL-lactide/glycolide copolymer (PLGA) nanospheres to prolong hypoglycemic effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.492212

Prolonged hypoglycemic effect of insulin-loaded polybutylcyanoacrylate nanoparticles after pulmonary administration to normal rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.492212

Surface-modified PLGA nanosphere with chitosan improved pulmonary delivery of calcitonin by mucoadhesion and opening of the intercellular tight junctions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.492212

Single dose and multiple dose studies of itraconazole nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.492212

Poly (DL-lactide-co-glycolide) nanoparticle-based inhalable sustained drug delivery system for experimental tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.492212

Nanoparticle encapsulated antitubercular drugs as a potential oral drug delivery system against murine tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.492212

Lectin-functionalized poly (lactide-co-glycolide) nanoparticles as oral/aerosolized antitubercular drug carriers for treatment of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.492212

Continuous cultures of fused cells secreting antibody of predefined specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.492212

Monoclonal antibody drug conjugates in the treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.492212

Drug-conjugated monoclonal antibodies for the treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.492212

Mannose receptor-mediated gene transfer into macrophages using novel mannosylated cationic liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.492212

Inhibition of liver metastasis by targeting of immunomodulators using mannosylated liposome carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.492212

Efficient targeting to alveolar macrophages by intratracheal administration of mannosylated liposomes in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.492212

A growth factor antagonist as a targeting agent for sterically stabilized liposomes in human small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.492212

Comparative permeability and diffusion kinetics of cyclosporine A liposomes and propylene glycol solution from human lung tissue into human blood ex vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.492212

Increased lung uptake of liposomes coated with polysaccharides

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.492212

Targeting Stealth liposomes in a murine model of human small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.492212

Targeting and anti-tumor efficacy of liposomal 5'-O-dipalmitoylphosphatidyl 2'-C-cyano-2'-deoxy-1-beta-D-arabino-pentofuranosylcytosine in mice lung bearing B16BL6 melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.492212

Nucleosides and nucleotides. 100. 2'-C-cyano-2'-deoxy-1-beta-D-arabinofuranosyl-cytosine (CNDAC): design of a potential mechanism-based DNA-strand-breaking antineoplastic nucleoside

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.492212

Efficient drug targeting to rat alveolar macrophages by pulmonary administration of ciprofloxacin incorporated into mannosylated liposomes for treatment of respiratory intracellular parasitic infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.492212

Chitosan-coated liposomes for delivery to lungs by nebulisation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.492212

Localization of sterically stabilized liposomes in experimental rat Klebsiella pneumoniae pneumonia: dependence on circulation kinetics and presence of poly(ethylene)glycol coating

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.492212

The effect of surface charge on the disposition of liposome-encapsulated gentamicin to the rat liver, brain, lungs and kidneys after intraperitoneal administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.492212

Dendrimers as therapeutic agents: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.492212

Dendrimeric nanoarchitectures mediated transdermal and oral delivery of bioactives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.492212

PEGylated PPI dendritic architectures for sustained delivery of H2 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.492212

Transport mechanism(s) of poly (amidoamine) dendrimers across Caco-2 cell monolayers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.492212

The effect of surface functionality on cellular trafficking of dendrimers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.492212

Enhancement of dendrimer-mediated transfection using synthetic lung surfactant exosurf neonatal in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.492212

Characterization of lactoferrin as a targeting ligand for nonviral gene delivery to airway epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.492212

Effects of niosomal cisplatin and combination of the same with theophylline and with activated macrophages in murine B16F10 melanoma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.492212

Intracellular macrophage uptake of rifampicin loaded mannosylated dendrimers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.2010.492212

10.1517/17425247.2010.492212

21 January 2018

Identifiers

DOI

1 reference

22 August 2017

1 reference